The nation of Zimbabwe has turned down a major American healthcare agreement worth $367m (272 million pounds) over five years because of the United States' insistence on sensitive information.
This rejection became public after a official document dated December was disclosed, indicating that Head of State Emmerson Mnangagwa deemed the deal was "skewed".
An official spokesperson has since clarified that the US was seeking genetic material for research and commercial purposes but refused to guarantee the benefits from future treatments.
"We must now begin the challenging and unfortunate task of ending our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy noted the US had provided over $1.9bn for health programmes to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has called for continued talks to secure a deal agreeable to both sides so the country's critical HIV treatment initiative can continue.
Wider Background
This development comes after a comparable situation in Kenya, where a court blocked a similar deal with the US following legal challenges were raised about the security of Kenyans' health data.
Since returning to the presidency recently, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).
The agency had administered assistance for the American government, but Trump claimed its spending was "inefficient" and his administration was seeking direct bilateral deals to enhance transparency and responsibility.
According to statements, Sixteen nations in Africa have so far signed similar health pacts, constituting over $18.3bn in committed funds.
Specifics of the Rejected Agreement
This assistance for Zimbabwe was intended to gone towards "tackling HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".
"We believe this partnership would have delivered immense benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently on antiretroviral therapy via American-funded initiatives," the Ambassador commented.
However, official spokesman Nick Mangwana argued the arrangement was "unfair".
"Our nation was requested to surrender its genetic material and health information for a long time, with no equivalent assurance of access to any scientific breakthroughs – like new medicines or tests – that could be developed from that shared data," Mangwana explained.
"Put simply, our nation would supply the basic resources for medical research without any certainty that the end products would be available to our citizens if a future pandemic emerge."
National Interest and International Frameworks
Mangwana further said that the American exit from the global health body and its push of bilateral health agreements were disrupting frameworks previously set up through the international health agency.
The spokesperson cited its Pandemic Benefit-Sharing scheme designed to deal with future pandemics.
"This system is designed to ensure that when a nation contributes its information, the benefits – such as vaccines and treatments – are distributed fairly, not commercialised solely by those with the resources to create them."
The government's concerns over the US deal "should not be misconstrued as opposition to America," Mangwana stressed.
"We encourage continued dialogue with our American counterparts on how subsequent collaboration might be designed in a manner that honours the sovereignty and dignity of each country."
Medical Community Reaction
Medical experts said it acknowledged the government's concerns, but suggested that talks should continue considering much of the nation's Aids initiatives relied on external financing.
"In cases where technical issues exist, such as those relating to data governance or implementation frameworks, these can often be resolved via technical clarification and negotiated safeguards," it added.
The halted deal emphasises the continuing challenges between accepting vital foreign assistance and safeguarding national sovereignty in an ever more interconnected world.